CTCBIO Inc (060590) — Capital Reinvestment Ratio
Latest as of September 2025:
0.04x
CTCBIO Inc (060590) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩5.64 Billion) in capital expenditures (₩212.02 Million). See CTCBIO Inc (060590) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
₩5.64 Billion
KRW
Capital Expenditures
₩212.02 Million
KRW
Data as of
Sep 2025
Most recent filing
CTCBIO Inc Capital Reinvestment Ratio (2013–2024)
This chart tracks CTCBIO Inc's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for CTCBIO Inc (2013–2024)
Year-by-year Capital Reinvestment Ratio for CTCBIO Inc from 2013 to 2024. For live market cap and broader valuation context, see 060590 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | ₩4.50 Billion | ₩2.14 Billion | ▲ +107.4% |
| 2023 | 0.23x | ₩8.22 Billion | ₩1.88 Billion | ▲ +31.8% |
| 2022 | 0.17x | ₩18.22 Billion | ₩3.17 Billion | ▼ -32.8% |
| 2021 | 0.26x | ₩6.46 Billion | ₩1.67 Billion | ▼ -93.1% |
| 2020 | 3.77x | ₩510.09 Million | ₩1.92 Billion | ▲ +185.2% |
| 2019 | 1.32x | ₩1.68 Billion | ₩2.22 Billion | ▼ -90.0% |
| 2017 | 13.22x | ₩295.30 Million | ₩3.90 Billion | ▲ +573.9% |
| 2016 | 1.96x | ₩6.86 Billion | ₩13.46 Billion | ▼ -88.1% |
| 2015 | 16.50x | ₩1.44 Billion | ₩23.71 Billion | ▲ +647.6% |
| 2013 | 2.21x | ₩2.74 Billion | ₩6.05 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow